Table 3.
Whole Study Population (n = 281) |
||||
---|---|---|---|---|
Parameters * | Rho *** | p ** | β ± SE **** | p ** |
Age (years) | −0.1426 | 0.0341 | ||
BMI (kg/m2) | −0.0691 | 0.3362 | ||
WC (cm) | 0.0495 | 0.4976 | ||
HC (cm) | −0.0720 | 0.3238 | ||
WHR | 0.1444 | 0.0469 | 0.2472 ± 0.1108 # | 0.0288 |
SBP (mmHg) | −0.1048 | 0.1210 | ||
DBP (mmHg) | −0.0858 | 0.2052 | ||
Creatinine (μmol/L) | 0.0362 | 0.5945 | ||
eGFR (mL/min/1.73 m2) | 0.1240 | 0.0670 | ||
FPG (mmol/L) | 0.0843 | 0.2205 | ||
PPG (mmol/L) | 0.0419 | 0.5427 | ||
HbA1c (%) | 0.0962 | 0.2246 | ||
Uric acid (μmol/L) | −0.0675 | 0.4248 | ||
TCH (mmol/L) | 0.0927 | 0.1810 | ||
LDL-CH (mmol/L) | 0.1255 | 0.0715 | ||
HDL-CH (mmol/L) | 0.0286 | 0.6836 | ||
TG (mmol/) | −0.0905 | 0.1935 | −0.5073 ± 0.2146 # | 0.0208 |
ALT (U/L) | 0.1284 | 0.0614 | ||
AST (U/L) | −0.0214 | 0.7557 | ||
Total bilirubin (μmol/L) | 0.0893 | 0.1983 | ||
GGTP (U/L) | −0.0872 | 0.2265 | −0.2730 ± 0.1345 # | 0.0461 |
HSI | −0.1431 | 0.0494 | ||
FLI | −0.1741 | 0.0263 |
* ALT—alanine aminotransferase, AST—aspartic aminotransferase, BMI—body mass index, DBP—diastolic blood pressure, eGFR—estimated glomerular filtration rate, HDL-CH—HDL cholesterol, HSI—Hepatic Steatosis Index, FLI—Fatty Liver Index, FPG—fasting plasma glucose, GGTP- gamma-glutamyltransferase, HbA1c—glycated hemoglobin, HC—hip circumference, LDL-CH—LDL cholesterol, NAFLD—non-alcoholic fatty liver disease, PPG—postprandial plasma glucose, SBP—systolic blood pressure, TCH—total cholesterol, TG—triglycerides, WC—waist circumference, WHR—waist-hip ratio. ** Rho—Spearman rank correlation coefficient. *** p-value. β ± SE ****—regression coefficient ± standard error. # variables were log-transformed prior to linear regression analysis. The bolded results indicate statistically significant associations.